BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 28735292)

  • 1. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
    Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.
    Montgomery DE; Tardiff JC; Chandra M
    J Physiol; 2001 Oct; 536(Pt 2):583-92. PubMed ID: 11600691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased myofilament Ca2+ sensitivity and diastolic dysfunction as early consequences of Mybpc3 mutation in heterozygous knock-in mice.
    Fraysse B; Weinberger F; Bardswell SC; Cuello F; Vignier N; Geertz B; Starbatty J; Krämer E; Coirault C; Eschenhagen T; Kentish JC; Avkiran M; Carrier L
    J Mol Cell Cardiol; 2012 Jun; 52(6):1299-307. PubMed ID: 22465693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice.
    Abraham TP; Jones M; Kazmierczak K; Liang HY; Pinheiro AC; Wagg CS; Lopaschuk GD; Szczesna-Cordary D
    Cardiovasc Res; 2009 Apr; 82(1):84-92. PubMed ID: 19150977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic cardiomyopathy-linked mutation in troponin T causes myofibrillar disarray and pro-arrhythmic action potential changes in human iPSC cardiomyocytes.
    Wang L; Kim K; Parikh S; Cadar AG; Bersell KR; He H; Pinto JR; Kryshtal DO; Knollmann BC
    J Mol Cell Cardiol; 2018 Jan; 114():320-327. PubMed ID: 29217433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy.
    Tardiff JC; Hewett TE; Palmer BM; Olsson C; Factor SM; Moore RL; Robbins J; Leinwand LA
    J Clin Invest; 1999 Aug; 104(4):469-81. PubMed ID: 10449439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lys184 deletion in troponin I impairs relaxation kinetics and induces hypercontractility in murine cardiac myofibrils.
    Iorga B; Blaudeck N; Solzin J; Neulen A; Stehle I; Lopez Davila AJ; Pfitzer G; Stehle R
    Cardiovasc Res; 2008 Mar; 77(4):676-86. PubMed ID: 18096573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troponin T and beta-myosin mutations have distinct cardiac functional effects in hypertrophic cardiomyopathy patients without hypertrophy.
    Revera M; van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
    Cardiovasc Res; 2008 Mar; 77(4):687-94. PubMed ID: 18029407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inotropic stimulation induces cardiac dysfunction in transgenic mice expressing a troponin T (I79N) mutation linked to familial hypertrophic cardiomyopathy.
    Knollmann BC; Blatt SA; Horton K; de Freitas F; Miller T; Bell M; Housmans PR; Weissman NJ; Morad M; Potter JD
    J Biol Chem; 2001 Mar; 276(13):10039-48. PubMed ID: 11113119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E22K mutation of myosin RLC that causes familial hypertrophic cardiomyopathy increases calcium sensitivity of force and ATPase in transgenic mice.
    Szczesna-Cordary D; Guzman G; Zhao J; Hernandez O; Wei J; Diaz-Perez Z
    J Cell Sci; 2005 Aug; 118(Pt 16):3675-83. PubMed ID: 16076902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in myofilament function contribute to left ventricular dysfunction in pigs early after myocardial infarction.
    van der Velden J; Merkus D; Klarenbeek BR; James AT; Boontje NM; Dekkers DH; Stienen GJ; Lamers JM; Duncker DJ
    Circ Res; 2004 Nov; 95(11):e85-95. PubMed ID: 15528471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac myosin heavy chain isoform exchange alters the phenotype of cTnT-related cardiomyopathies in mouse hearts.
    Rice R; Guinto P; Dowell-Martino C; He H; Hoyer K; Krenz M; Robbins J; Ingwall JS; Tardiff JC
    J Mol Cell Cardiol; 2010 May; 48(5):979-88. PubMed ID: 20004663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T.
    Javadpour MM; Tardiff JC; Pinz I; Ingwall JS
    J Clin Invest; 2003 Sep; 112(5):768-75. PubMed ID: 12952925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal and mutation-specific alterations in Ca2+ homeostasis differentially determine the progression of cTnT-related cardiomyopathies in murine models.
    Guinto PJ; Haim TE; Dowell-Martino CC; Sibinga N; Tardiff JC
    Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H614-26. PubMed ID: 19502551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants.
    Davis J; Wen H; Edwards T; Metzger JM
    J Mol Cell Cardiol; 2008 May; 44(5):891-904. PubMed ID: 18423659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic troponin T mutants with opposing effects on myofilament Ca
    Dieseldorff Jones KM; Koh Y; Weller RS; Turna RS; Ahmad F; Huke S; Knollmann BC; Pinto JR; Hwang HS
    Arch Biochem Biophys; 2019 Jan; 661():125-131. PubMed ID: 30445044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy.
    Yanaga F; Morimoto S; Ohtsuki I
    J Biol Chem; 1999 Mar; 274(13):8806-12. PubMed ID: 10085122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice.
    Lutucuta S; Tsybouleva N; Ishiyama M; Defreitas G; Wei L; Carabello B; Marian AJ
    J Am Coll Cardiol; 2004 Dec; 44(11):2221-30. PubMed ID: 15582321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered regulation of cardiac muscle contraction by troponin T mutations that cause familial hypertrophic cardiomyopathy.
    Knollmann BC; Potter JD
    Trends Cardiovasc Med; 2001 Jul; 11(5):206-12. PubMed ID: 11597833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.